VA awards $25.7M for Blood Product Reagents to QuidelOrtho Sales Company, LLC
Contract Overview
Contract Amount: $25,773 ($25.8K)
Contractor: Quidelortho Sales Company, LLC
Awarding Agency: Department of Veterans Affairs
Start Date: 2025-10-01
End Date: 2026-03-31
Contract Duration: 181 days
Daily Burn Rate: $142/day
Competition Type: FULL AND OPEN COMPETITION
Number of Offers Received: 1
Pricing Type: FIRM FIXED PRICE
Sector: Healthcare
Official Description: BLOOD PRODUCT REAGENTS
Place of Performance
Location: SAN DIEGO, SAN DIEGO County, CALIFORNIA, 92121
Plain-Language Summary
Department of Veterans Affairs obligated $25,772.64 to QUIDELORTHO SALES COMPANY, LLC for work described as: BLOOD PRODUCT REAGENTS Key points: 1. Contract awarded for essential blood product reagents, critical for laboratory diagnostics. 2. Competition method was 'Full and Open', suggesting a competitive bidding process. 3. The contract duration is 181 days, indicating a short-term need. 4. The awarding agency is the Department of Veterans Affairs, serving veteran healthcare needs.
Value Assessment
Rating: fair
The contract value of $25.7M for a 181-day period suggests a significant per-diem cost. Without specific unit details or historical benchmarks for these reagents, a precise value assessment is difficult. However, the firm fixed price suggests cost certainty for the VA.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
The 'Full and Open Competition' method implies that multiple vendors had the opportunity to bid, which typically drives competitive pricing. The final price is determined by the bids received, aiming for the best value for the government.
Taxpayer Impact: The competitive bidding process is intended to ensure taxpayer funds are used efficiently, securing necessary reagents at a reasonable market price.
Public Impact
Ensures availability of critical diagnostic reagents for veteran healthcare. Supports laboratory operations within the Department of Veterans Affairs. Potential impact on the supply chain for specialized blood products.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Warning Flags
- Short contract duration may lead to frequent re-solicitation and potential price fluctuations.
- Lack of specific unit cost data makes detailed value analysis challenging.
- Dependence on a single awardee for a critical supply.
Positive Signals
- Full and open competition utilized.
- Firm fixed price contract provides cost predictability.
- Awarded to a known entity, potentially indicating established supply chain relationships.
Sector Analysis
This contract falls under the 'Analytical Laboratory Instrument Manufacturing' sector, specifically for reagents. Spending in this area is crucial for healthcare diagnostics and research. Benchmarks would typically compare reagent costs against similar government or commercial contracts for comparable products and volumes.
Small Business Impact
The data does not indicate if small businesses were involved in this specific contract award. Further analysis would be needed to determine the extent of small business participation in the supply chain or as potential subcontractors.
Oversight & Accountability
The Department of Veterans Affairs is responsible for overseeing this contract to ensure timely delivery and quality of the blood product reagents. Accountability rests on meeting the terms and conditions outlined in the delivery order.
Related Government Programs
- Analytical Laboratory Instrument Manufacturing
- Department of Veterans Affairs Contracting
- Department of Veterans Affairs Programs
Risk Flags
- Short contract duration
- Lack of detailed unit cost data
- Potential for supply chain disruption
- Limited visibility into specific reagent types and quantities
Tags
analytical-laboratory-instrument-manufac, department-of-veterans-affairs, ca, delivery-order, under-100k
Frequently Asked Questions
What is this federal contract paying for?
Department of Veterans Affairs awarded $25,772.64 to QUIDELORTHO SALES COMPANY, LLC. BLOOD PRODUCT REAGENTS
Who is the contractor on this award?
The obligated recipient is QUIDELORTHO SALES COMPANY, LLC.
Which agency awarded this contract?
Awarding agency: Department of Veterans Affairs (Department of Veterans Affairs).
What is the total obligated amount?
The obligated amount is $25,772.64.
What is the period of performance?
Start: 2025-10-01. End: 2026-03-31.
What is the projected per-unit cost of these blood product reagents, and how does it compare to market averages?
The provided data does not include specific unit costs or quantities, making a direct per-unit cost calculation and market comparison impossible. The total award of $25.7M over 181 days suggests a high daily expenditure. To assess value, a breakdown of reagent types, quantities, and their respective prices would be necessary, alongside industry benchmarks for similar diagnostic supplies.
What are the potential risks associated with the short 181-day contract duration for such critical reagents?
A short contract duration like 181 days for essential reagents poses risks of supply chain disruption if a new contract is not awarded promptly. It can also lead to increased administrative costs due to frequent re-solicitation and potentially higher prices if competition is limited in subsequent rounds. This necessitates proactive planning for contract renewal or replacement.
How effectively does the 'Full and Open Competition' method ensure the best value for taxpayers in this specific procurement?
The 'Full and Open Competition' method is designed to maximize competition, theoretically leading to the best value. However, its effectiveness depends on the number and quality of bids received. If only a few vendors participated, or if the evaluation criteria did not adequately weigh factors beyond price, the achieved value might be suboptimal. A review of the bidding process and award justification would clarify effectiveness.
Industry Classification
NAICS: Manufacturing › Navigational, Measuring, Electromedical, and Control Instruments Manufacturing › Analytical Laboratory Instrument Manufacturing
Product/Service Code: INSTRUMENTS AND LABORATORY EQPT
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION
Solicitation Procedures: SUBJECT TO MULTIPLE AWARD FAIR OPPORTUNITY
Offers Received: 1
Pricing Type: FIRM FIXED PRICE (J)
Evaluated Preference: NONE
Contractor Details
Address: 9975 SUMMERS RIDGE RD, SAN DIEGO, CA, 92121
Business Categories: Category Business, Corporate Entity Not Tax Exempt, Limited Liability Corporation, Not Designated a Small Business, Special Designations, U.S.-Owned Business
Financial Breakdown
Contract Ceiling: $25,773
Exercised Options: $25,773
Current Obligation: $25,773
Contract Characteristics
Commercial Item: COMMERCIAL PRODUCTS/SERVICES
Parent Contract
Parent Award PIID: V797D60637
IDV Type: FSS
Timeline
Start Date: 2025-10-01
Current End Date: 2026-03-31
Potential End Date: 2026-03-31 00:00:00
Last Modified: 2026-04-02
More Contracts from Quidelortho Sales Company, LLC
- Lease of Ortho Vision and Reagents — $838.5K (Department of Veterans Affairs)
- ::blood Bank Analyzer:: — $172.7K (Department of Veterans Affairs)
- Blood Bank Testing Quality Control for Boise VA Medical Center — $66.1K (Department of Veterans Affairs)
- Blook Bank Testing Supplies — $45.2K (Department of Veterans Affairs)
- Quidelorthro Triage Meterpro Reagents and Supplies — $40.8K (Department of Veterans Affairs)
Other Department of Veterans Affairs Contracts
- CCN Region 3 Express Report — $5.2B (Optum Public Sector Solutions, Inc.)
- Express Report for FY22 Region 2 — $5.1B (Optum Public Sector Solutions, Inc.)
- Fiscal Year 2022 Express Report for Region 1 — $4.2B (Optum Public Sector Solutions, Inc.)
- Express Report for the Patient Centered Community Care (PC3) Contract — $3.3B (Triwest Healthcare Alliance Corp)
- CCN Region Three FY21 Express Report — $3.1B (Optum Public Sector Solutions, Inc.)